ALOX12
ALOX12 (arachidonate 12-lipoxygenase, 12S type, also known as 12S-LOX) is a member of the lipoxygenase family. It oxygenates polyunsaturated fatty acids, mainly arachidonate, to produce bioactive lipid mediators that regulate processes such as platelet activation. Browse Assay Genie's current range of ALOX12 research reagents below, or read on for the biology behind the target.
ALOX12 catalyses the regio- and stereo-specific incorporation of molecular oxygen into free and esterified polyunsaturated fatty acids. This generates lipid hydroperoxides, which can be reduced further to the corresponding hydroxy species. Its main reaction converts arachidonate to the bioactive lipid (12S)-hydroperoxyeicosatetraenoate, or (12S)-HPETE. Through this and related lipids, ALOX12 regulates several biological processes, including platelet activation. It can also peroxidize linoleate to (13S)-HPODE and catalyse epoxidation of double bonds in fatty acids such as (14S)-HPDHA, giving (13S,14S)-epoxy-DHA.
The enzyme may also take part in sequential oxidation of DHA to specialised pro-resolving mediators, including resolvin D5 and (7S,14S)-diHPDHA, which down-regulate the immune response and have anti-aggregation effects on platelets. In a further multistep activity, it transforms leukotriene A4 into lipoxin A4 and lipoxin B4. Both are vasoactive, and lipoxin A4 may regulate neutrophil function. UniProt annotates the protein as being found in the cytosol and in association with membranes, and places it in the lipoxygenase family. The human ALOX12 gene sits in the HGNC group of arachidonate lipoxygenases, and mouse and rat each have an Alox12 ortholog.
ALOX12 has also been linked to cell survival and disease. It regulates expression of vascular endothelial growth factor and integrin beta-1, and so can be regarded as protumorigenic. It may support proliferation and prevent apoptosis in vascular smooth muscle cells. NCBI Gene reports elevated expression in pancreatic islets from people with diabetes, and notes that allelic variants may be associated with susceptibility to toxoplasmosis. Multiple pseudogenes of this gene are present in the human genome.
ALOX12 and its products, such as (12S)-HPETE, regulate platelet activation and function, making it a focus for haemostasis research.
The enzyme generates eicosanoids, lipoxins and pro-resolving mediators from polyunsaturated fatty acids, so it is studied in bioactive lipid pathways.
Through effects on VEGF and integrin beta-1 expression, ALOX12 can be regarded as protumorigenic, relevant to tumour angiogenesis, migration and proliferation.
Elevated expression in pancreatic islets from people with diabetes, and roles in immune regulation, make ALOX12 relevant to metabolic and inflammatory studies.
ALOX12 is a lipoxygenase that inserts molecular oxygen into polyunsaturated fatty acids. Its main product is (12S)-HPETE from arachidonate, a bioactive lipid that regulates processes including platelet activation. It also contributes to lipoxin and pro-resolving mediator synthesis. Check the datasheet of any product for its validated reactivity.
ALOX12 is the HGNC symbol for arachidonate 12-lipoxygenase, 12S type, also called 12S-LOX. Its previous name was arachidonate 12-lipoxygenase. UniProt lists the protein as polyunsaturated fatty acid lipoxygenase ALOX12, and it belongs to the arachidonate lipoxygenases gene group.
NCBI Gene reports elevated ALOX12 expression in pancreatic islets from people with diabetes, and allelic variants may be associated with susceptibility to toxoplasmosis. UniProt also notes that its effects on VEGF and integrin beta-1 expression mean it can be regarded as protumorigenic. Mouse and rat both have an Alox12 ortholog.
Other arachidonate lipoxygenases and related lipid-mediator pathway proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P18054; product specifications from Assay Genie datasheets.